These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 33807854)
1. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries. Liang C; Bencurova E; Psota E; Neurgaonkar P; Prelog M; Scheller C; Dandekar T Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807854 [TBL] [Abstract][Full Text] [Related]
2. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research. Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143 [TBL] [Abstract][Full Text] [Related]
3. Landscape and selection of vaccine epitopes in SARS-CoV-2. Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools. Prachar M; Justesen S; Steen-Jensen DB; Thorgrimsen S; Jurgons E; Winther O; Bagger FO Sci Rep; 2020 Nov; 10(1):20465. PubMed ID: 33235258 [TBL] [Abstract][Full Text] [Related]
5. Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2. Wilson EA; Hirneise G; Singharoy A; Anderson KS Cell Rep Med; 2021 Mar; 2(3):100221. PubMed ID: 33649748 [TBL] [Abstract][Full Text] [Related]
8. Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups? Bose T; Pant N; Pinna NK; Bhar S; Dutta A; Mande SS Virus Res; 2021 Nov; 305():198579. PubMed ID: 34560183 [TBL] [Abstract][Full Text] [Related]
9. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein. Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022 [TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country. Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O Front Immunol; 2020; 11():2008. PubMed ID: 33013857 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
12. Computational Prediction of Usutu Virus E Protein B Cell and T Cell Epitopes for Potential Vaccine Development. Palanisamy N; Lennerstrand J Scand J Immunol; 2017 May; 85(5):350-364. PubMed ID: 28273384 [TBL] [Abstract][Full Text] [Related]
13. Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern. López D Front Immunol; 2022; 13():832889. PubMed ID: 35154154 [TBL] [Abstract][Full Text] [Related]
14. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population. Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L Front Immunol; 2024; 15():1357731. PubMed ID: 38784379 [TBL] [Abstract][Full Text] [Related]
15. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. de Sousa E; Ligeiro D; Lérias JR; Zhang C; Agrati C; Osman M; El-Kafrawy SA; Azhar EI; Ippolito G; Wang FS; Zumla A; Maeurer M Int J Infect Dis; 2020 Sep; 98():454-459. PubMed ID: 32693089 [TBL] [Abstract][Full Text] [Related]
16. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers. Poluektov Y; George M; Daftarian P; Delcommenne MC Vaccine; 2021 Apr; 39(15):2110-2116. PubMed ID: 33744048 [TBL] [Abstract][Full Text] [Related]
17. In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses. Castro A; Ozturk K; Zanetti M; Carter H PLoS One; 2021; 16(2):e0246731. PubMed ID: 33571241 [TBL] [Abstract][Full Text] [Related]
18. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Oliveira SC; de Magalhães MTQ; Homan EJ Front Immunol; 2020; 11():587615. PubMed ID: 33193414 [TBL] [Abstract][Full Text] [Related]
19. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population. Moura RR; Agrelli A; Santos-Silva CA; Silva N; Assunção BR; Brandão L; Benko-Iseppon AM; Crovella S J Clin Pathol; 2021 Aug; 74(8):528-532. PubMed ID: 32759312 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. Kiyotani K; Toyoshima Y; Nemoto K; Nakamura Y J Hum Genet; 2020 Jul; 65(7):569-575. PubMed ID: 32372051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]